Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mG (Q45356884)
Jump to navigation
Jump to search
scientific article published on 15 December 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mG |
scientific article published on 15 December 2010 |
Statements
Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective (English)
Filippo Caraci
Gemma Molinaro
Barbara Riozzi
Xushan Wang
Beverly A Heinz
Eric S Nisenbaum
Thomas C Britton
Agata Copani
15 December 2010
1 reference